Physician profile
Scott E Rosenthal
NPI 1861494023
$7,992.87
in general payments reported to CMS, 2019-2025
34 companies · $699 in 2025
The $699 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $1,822 · 2021: $963 · 2022: $1,771 · 2023: $1,209 · 2024: $945 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,852.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,243.22 | 2019-2025 | Wavewriter Alpha Prime 16, Infinion 16, Intracept |
| Abbott Laboratories | $1,618.57 | 2019-2025 | Proclaim, Eterna, Octrode |
| Vertos Medical, INC. | $806.49 | 2019-2024 | Mild Device Kit |
| Si-Bone, INC. | $432.77 | 2021-2024 | |
| Nevro Corp. | $347.98 | 2019-2023 | Senza |
| Medtronic, INC. | $294.29 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $151.31 | 2022-2023 | Seglentis |
| Foundation Fusion Solutions, LLC | $143.87 | 2022-2025 | |
| Electronic Waveform Lab, INC. | $113.17 | 2021-2023 | |
| Scilex Pharmaceuticals INC. | $69.49 | 2019-2021 | |
| Abbvie INC. | $67.46 | 2022-2024 | Ubrelvy |
| Relievant Medsystems, INC. | $67.13 | 2021-2022 | |
| Biotronik Nro, INC. | $64.68 | 2025 | Prospera |
| Nalu Medical, INC. | $61.01 | 2022-2024 | Nalu Neurostimulation System |
| Lilly USA, LLC | $53.77 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $40.46 | 2023 | Reactiv8 |
| Arbor Pharmaceuticals, INC. | $38.53 | 2021 | |
| Vertiflex, INC. | $37.38 | 2019 | |
| Grt US Holding, INC. | $36.63 | 2021-2022 | |
| Pfizer INC. | $35.55 | 2021 | |
| Saluda Medical Americas, INC. | $28.20 | 2024-2025 | Evoke |
| Curonix LLC | $26.05 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $24.00 | 2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $22.30 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.15 | 2025 | Exparel |
| Galderma Laboratories, L.P. | $18.50 | 2024 | Dysport |
| Painteq LLC | $18.43 | 2024 | Painteq |
| Averitas Pharma INC. | $18.36 | 2024 | Qutenza |
| Globus Medical, INC. | $18.21 | 2025 | Vyrsa V1 |
| Baudax Bio INC. | $16.17 | 2022 | |
| Tersera Therapeutics LLC | $14.97 | 2019 | |
| Zyla Life Sciences, INC. | $14.57 | 2019 | |
| Azurity Pharmaceuticals, INC. | $14.44 | 2023 | Horizant |
| Assertio Therapeutics, INC. | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Rosenthal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.